Regulatory Approvals Trigger Growth For AI Medical Imaging

According to Frost & Sullivan, medical imaging has become the bellwether for the application of artificial intelligence (AI) technologies, especially deep learning techniques in the healthcare space. Example, over 90 companies are at various stages of development and commercialization of AI-based solutions for the medical imaging industry. This number continues to grow as startups emerge, the incumbents develop native AI solutions, and technology companies move into the field. With many countries edging past the innovator adoption phase and into the early adopter one, the stakeholders should now focus on refining and testing their value proposition, partnership approach, and go-to-market strategies.

 

Frost & Sullivan’s recent analysis, Artificial Intelligence for Medical Image Analysis—Companies-to-Action, 2018, examines the regional differences, regulatory developments, growth opportunities, funding investments, imaging modalities, clinical specialties, organs and disease states targeted by AI solutions, plus the top 10 predictions for the future of this industry. It also highlights the use cases that will take off in the market and the key companies that will disrupt traditional medical image analysis workflows.

Fierce AI Week

Register today for Fierce AI Week - a free virtual event | August 10-12

Advances in AI and Machine Learning are adding an unprecedented level of intelligence to everything through capabilities such as speech processing and image & facial recognition. An essential event for design engineers and AI professionals, Engineering AI sessions during Fierce AI Week explore some of the most innovative real-world applications today, the technological advances that are accelerating adoption of AI and Machine Learning, and what the future holds for this game-changing technology.

 

These advances in AI for medical imaging are evident across the globe, but each country has a different incentive and vision. Some developed countries such as the United States require higher productivity and standardization. However, other countries such as the United Kingdom need to address shortages and higher wait times, and the developing ones such as China may need it to build access and expertise to improve diagnosis rates.

 

Growth opportunities include:

  • Acceleration, automation and augmentation of medical image analysis;
  • Cloud-based, on-demand access through medical imaging AI marketplaces;
  • Cognitive applications to orchestrate and optimize the medical imaging workflow; and
  • The advent of intelligent medical imaging machines with embedded AI.

The regulatory agencies are granting approvals for AI-based solutions and opening doors for commercialization, allowing for the billions of dollars invested in the development of these technologies to see some return on investment (ROI) in the coming years. For more insights, visit Frost & Sullivan’s global Advanced Medical Technologies Growth Partnership Service program.

Suggested Articles

Iowa State University researchers are working with NSF grant

Brain Corp. reported a sharp increase in autonomous robot usage in 2Q

Nvidia DGX accelerators helped train system from 150,000 chest X-rays with inference results in less than a second